
Data by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer vaccine, jointly developed by BioNTech , was 89.7% effective in preventing infection at least two weeks after a first dose was given, while the AstraZeneca shot was 86.0% effective.
from International-News-Economic Times https://ift.tt/3b2dwyx
via
IFTTT
0 comments:
Post a Comment